Our history

The history of dne pharma stretches back to 2 February 1900, when the Norwegian Ether Factory (DnE) was founded. Originally, the factory was established to produce ether for the Norwegian market at a time when there were no other suppliers.

From the beginning

Den norske Eterfabrikk was founded at Bøler in Oslo, and the site was chosen so that the factory would be far enough away from other buildings in the event of an explosion. For many years, ether was the main product at the factory. Initially, ether was primarily used by pharmacists, but after World War I, it was also used as an anaesthetic. During World War II, the factory was classified as a critically important business because of the great need for ether as an anaesthetic and in the production of gunpowder.

After the war and right up to the present day, the factory has been producing chemical substances such as formaldehyde and collodion, as well as, for a time, chemicals for the printing industry.

In the mid-70s, the factory took a major step towards becoming purely a manufacturer of pharmaceuticals, when the bottling of flammable drugs for the Norwegian Pharmacy Association was moved to DnE. In the early 80s, the company was also contracted to manufacture flammable drugs for private pharmaceutical companies.

In the early 2000s, DnE began production of the first drug with marketing authorisation and it is still one of dne pharma’s main products. DnE also produced lice treatment products, creams and ointments for the Norwegian Pharmacy Association as well as some cosmetic products.

In 2012, DnE was acquired by Farma Holding and production was moved from the old factory to new and modern facilities at Karihaugen. The company was later merged with Apotekproduksjon under the DnE name and the business expanded to include the sale of raw materials, clinical services and analytical services. In the spring of 2016, a strategic decision was made to divide the manufacturing part of the company into a new company, Sanivo Pharma, while DnE was renamed dne pharma. The new company, dne pharma, retains all the same marketing authorisations and pipeline products.

 

 

Today

dne pharma is one of the leading suppliers within addiction medicine in the Nordic area. We have extensive experience and competence within this area of medicine, and we have new interesting products in pipeline. In addition to our core business, we also focus on treatment of pain and skin therapy.